{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T16:28:14Z","timestamp":1788366494709,"version":"build-2803163510"},"reference-count":33,"publisher":"Japan Endocrine Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2005]]},"DOI":"10.1507\/endocrj.52.735","type":"journal-article","created":{"date-parts":[[2006,1,12]],"date-time":"2006-01-12T05:56:19Z","timestamp":1137045379000},"page":"735-741","source":"Crossref","is-referenced-by-count":25,"title":["Effect of High Dose Methylprednisolone Pulse Therapy Followed by Oral Prednisolone Administration on the Production of Anti-TSH Receptor Antibodies and Clinical Outcome in Graves' Disease"],"prefix":"10.1507","volume":"52","author":[{"given":"Sumihisa","family":"KUBOTA","sequence":"first","affiliation":[{"name":"Kuma Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidemi","family":"OHYE","sequence":"additional","affiliation":[{"name":"Kuma Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eijun","family":"NISHIHARA","sequence":"additional","affiliation":[{"name":"Kuma Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"KUDO","sequence":"additional","affiliation":[{"name":"Kuma Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"ITO","sequence":"additional","affiliation":[{"name":"Kuma Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"FUKATA","sequence":"additional","affiliation":[{"name":"Kuma Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"AMINO","sequence":"additional","affiliation":[{"name":"Kuma Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanji","family":"KUMA","sequence":"additional","affiliation":[{"name":"Kuma Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"MIYAUCHI","sequence":"additional","affiliation":[{"name":"Kuma Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Werner SC, Platman SR (1965) Remission of hyperthyroidism (Graves' disease) and altered pattern of serum-thyroxine binding induced by prednisone. Lancet 2: 751-755.","DOI":"10.1016\/S0140-6736(65)90810-X"},{"key":"2","unstructured":"2. Peter SA (1991) Remission of Graves' disease with hyperthyroidism by a combination of glucocorticoids and antithyroid drugs. J Natl Med Assoc 83: 261-264."},{"issue":"4","key":"3","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1507\/endocrj.44.575","volume":"44","author":"MORI T","year":"1997","ISSN":"https:\/\/id.crossref.org\/issn\/0918-8959","issn-type":"print"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Nagayama Y, Izumi M, Kiriyama T, Yokoyama N, Morita S, Kakezono F, Ohtakara S, Morimoto I, Okamoto S, Nagataki S (1987) Treatment of Graves' ophthalmopathy with high-dose intravenous methylprednisolone pulse therapy. Acta Endocrinol (Copenh) 116: 513-518.","DOI":"10.1530\/acta.0.1160513"},{"issue":"6663","key":"5","first-page":"1574","volume":"297","year":"1988","ISSN":"https:\/\/id.crossref.org\/issn\/0959-8146","issn-type":"print"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Marcocci C, Bartalena L, Bogazzi F, Bruno-Bossio G, Lepri A, Pinchera A (1991) Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves' ophthalmopathy is more effective than radiotherapy alone: results of a prospective randomized study. J Endocrinol Invest 14: 853-860.","DOI":"10.1007\/BF03347943"},{"issue":"1","key":"7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1507\/endocrj.40.63","volume":"40","author":"HIROMATSU Y","year":"1993","ISSN":"https:\/\/id.crossref.org\/issn\/0918-8959","issn-type":"print"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Koshiyama H, Koh T, Fujiwara K, Hayakawa K, Shimbo S, Misaki T (1994) Therapy of Graves' ophthalmopathy with intravenous high-dose steroid followed by orbital irradiation. Thyroid 4: 409-413.","DOI":"10.1089\/thy.1994.4.409"},{"issue":"6","key":"9","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1507\/endocrj.43.689","volume":"43","author":"TAGAMI T","year":"1996","ISSN":"https:\/\/id.crossref.org\/issn\/0918-8959","issn-type":"print"},{"key":"10","unstructured":"10. Chang TC, Kao SC, Hsiao YL, Lu CP, Huang KM, Tzeng SS (1996) Therapeutic responses to corticosteroids in Graves' ophthalmopathy. J Formos Med Assoc 95: 833-838."},{"issue":"2","key":"11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1055\/s-2007-978843","volume":"30","year":"1998","ISSN":"https:\/\/id.crossref.org\/issn\/0018-5043","issn-type":"print"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.8.3562"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Macchia PE, Bagattini M, Lupoli G, Vitale M, Vitale G, Fenzi G (2001) High-dose intravenous corticosteroid therapy for Graves' ophthalmopathy. J Endocrinol Invest 24: 152-158.","DOI":"10.1007\/BF03343835"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Kauppinen-Makelin R, Karma A, Leinonen E, Loyttyniemi E, Salonen O, Sane T, Setala K, Viikari J, Heufelder A, Valimaki M (2002) High dose intravenous methylprednisolone pulse therapy versus oral prednisone for thyroid-associated ophthalmopathy. Acta Ophthalmol Scand 80: 316-321.","DOI":"10.1034\/j.1600-0420.2002.800316.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ohtsuka K, Sato A, Kawaguchi S, Hashimoto M, Suzuki Y (2003) Effect of steroid pulse therapy with and without orbital radiotherapy on Graves' ophthalmopathy. Am J Ophthalmol 135: 285-290.","DOI":"10.1016\/S0002-9394(02)01970-0"},{"key":"16","unstructured":"16. Cidlowski JA, King KL, Evans-Storms RB, Montague JW, Bortner CD, Hughes FM Jr (1996) The biochemistry and molecular biology of glucocorticoid-induced apoptosis in the immune system. Recent Prog Horm Res 51: 457-490."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Sabir S, Werth VP (2000) Pulse glucocorticoids. Dermatol Clin 18: 437-446.","DOI":"10.1016\/S0733-8635(05)70192-3"},{"key":"18","unstructured":"18. Sato A, Takemura Y, Yamada T, Ohtsuka H, Sakai H, Miyahara Y, Aizawa T, Terao A, Onuma S, Junen K, Kanamori A, Nakamura Y, Tejima E, Ito Y, Kamijo K (1999) A possible role of immunoglobulin E in patients with hyperthyroid Graves' disease. J Clin Endocrinol Metab 84: 3602-3605."},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.8.2775"},{"key":"20","unstructured":"20. Komiya I, Yamada T, Sato A, Kouki T, Nishimori T, Takasu N (2001) Remission and recurrence of hyperthyroid Graves' disease during and after methimazole treatment when assessed by IgE and interleukin 13. J Clin Endocrinol Metab 86: 3540-3544."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Donaldson SS, Bagshaw MA, Kriss JP (1973) Supervoltage orbital radiotherapy for Graves' ophthalmopathy. J Clin Endocrinol Metab 37: 276-285.","DOI":"10.1210\/jcem-37-2-276"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. De Bellis A, Bizzarro A, Conte M, Coronella C, Solimeno S, Perrino S, Sansone D, Guaglione M, Wall JR, Bellastella A (2003) Relationship between longitudinal behaviour of some markers of eye autoimmunity and changes in ocular findings in patients with Graves' ophthalmopathy receiving corticosteroid therapy. Clin Endocrinol (Oxf) 59: 388-395.","DOI":"10.1046\/j.1365-2265.2003.01861.x"},{"key":"23","unstructured":"23. Young ET, Steel NR, Taylor JJ, Stephenson AM, Stratton A, Holcombe M, Kendall-Taylor P (1988) Prediction of remission after antithyroid drug treatment in Graves' disease. Q J Med 66: 175-189."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Vitti P, Rago T, Chiovato L, Pallini S, Santini F, Fiore E, Rocchi R, Martino E, Pinchera A (1997) Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment. Thyroid 7: 369-375.","DOI":"10.1089\/thy.1997.7.369"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Orgiazzi J, Madec AM (2002) Reduction of the risk of relapse after withdrawal of medical therapy for Graves' disease. Thyroid 12: 849-853.","DOI":"10.1089\/105072502761016467"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Yamada T, Aizawa T, Koizumi Y, Komiya I, Ichikawa K, Hashizume K (1994) Age-related therapeutic response to antithyroid drug in patients with hyperthyroid Graves' disease. J Am Geriatr Soc 42: 513-516.","DOI":"10.1111\/j.1532-5415.1994.tb04973.x"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Schleusener H, Schwander J, Fischer C, Holle R, Holl G, Badenhoop K, Hensen J, Finke R, Bogner U, Mayr WR (1989) Prospective multicentre study on the prediction of relapse after antithyroid drug treatment in patients with Graves' disease. Acta Endocrinol (Copenh) 120: 689-701.","DOI":"10.1530\/acta.0.1200689"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Mysliwiec J, Kretowski A, Stepien A, Kinalska I (2004) Serum levels of soluble TNFalpha receptors (sTNFR1 and sTNFR2) during corticosteroid treatment in patients with Graves' ophthalmopathy. Immunol Invest 33: 61-68.","DOI":"10.1081\/IMM-120027685"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Mysliwiec J, Kretowski A, Stepien A, Mironczuk K, Kinalska I (2003) Interleukin 18 and transforming growth factor beta1 in the serum of patients with Graves' ophthalmopathy treated with corticosteroids. Int Immunopharmacol 3: 549-552.","DOI":"10.1016\/S1567-5769(03)00045-6"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Kumar S, Bahn RS (2003) Relative overexpression of macrophage-derived cytokines in orbital adipose tissue from patients with Graves' ophthalmopathy. J Clin Endocrinol Metab 88: 4246-4250.","DOI":"10.1210\/jc.2003-030380"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Raikow RB, Dalbow MH, Kennerdell JS, Compher K, Machen L, Hiller W, Blendermann D (1990) Immunohistochemical evidence for IgE involvement in Graves' orbitopathy. Ophthalmology 97: 629-635.","DOI":"10.1016\/S0161-6420(90)32548-4"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Raikow RB, Tyutyunikov A, Kennerdell JS, Kazim M, Dalbow MH, Scalise D (1992) Correlation of serum immunoglobulin E elevations with clinical stages of dysthyroid orbitopathy. Ophthalmology 993: 361-365.","DOI":"10.1016\/S0161-6420(92)31964-5"},{"key":"33","unstructured":"33. Molnar I, Horvath S, Balazs C (1996) Detectable serum IgE levels in Graves' ophthalmopathy. Eur J Med Res 1: 543-546."}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/52\/6\/52_6_735\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T06:00:10Z","timestamp":1618293610000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/52\/6\/52_6_735\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.52.735","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005]]}}}